Abstract
Increase of 3-hydroxykynurenine (3-HKYN) concentration was observed in plasma patients with chronic renal insufficiency (CRI). These changes positively correlated with the concentration of creatinine, but negatively correlated with haematological parameters: haematocrit, haemoglobin and red blood cells count. The changes were accompanied by a slight decrease of the concentration of erythropoietin (EPO) in plasma of patients with CRI. The “in vitro” study in the conditions of hypoxia showed that 3-HKYN inhibited the release of EPO from HepG2 cells to the culture base. In conclusion, the erythropoiesis in CRI could be attributed to the influence of 3-HKYN on EPO synthesis. Thus, we propose that 3-HKYN can be an uraemic of toxin partially responsible for anaemia patients with CRI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
K.U. Eckardt, Pathophysiology of renal anemiaClin. Nephrol. 53,S2–S8 (2000).
I. Macdougall, Role of uremic toxins in exacerbating anemia in renal failureKidney lnt 59 S67–S72 (2001).
W. Jelkman, T. Hellwing-Burgel, Biology of erythropoietinAdv. Exp. Med. Bio.l 502,169–87 (2001).
A.J. Erslev, A. Besarab, Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failureKidney /nt. 51,622–630 (1997).
K. Saito, S. Fujigaki, M.P. Heyes, K. Shibata, M. Takemura, H. Fujii, H. Wada, A. Noma, M. Seishima, Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiencyAm. J. Physiol. 279,F565–F572 (2000).
E.W. Holmes, S.E. Kahan, Tryptophan distribution and metabolism in experimental chronic renal insufficiencyExp. Mol. Pathol. 46,89–101 (1987).
E.W. Holmes, P.M. Russell, G.J. Kinzler, C.R. Reckard, R.C. Flanigan, K.D. Thompson, E.W. Berme, Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapyCytokine 4,205–213 (1992).
D. Pawlak, A. Tankiewicz, P. Mysliwiec, W. Buczko, Tryptophan metabolism via kynurenine pathway in experimental chronic renal failureNephron 90,328–335 (2002).
D. Pawlak, A. Tankiewicz, W. Buczko, Kynurenine and its metabolites in the rat with experimental renal insufficiencyJ. Physiol. Phrarmncol. 52,755–766 (2001).
D. Pawlak, K. Pawlak, J. Malyszko, M. Mysliwiec, W. Buczko, Accumulation of toxic products degradation of kynurenine in hemodialyzed patientsInt. Urol. Nephrol. 33,399–404 (2001).
R. Buchi, D. Alberati-Gani, P. Malherbe, C. Kohler, C. Broger, A.M. Cesura, Cloning and functional expression of a soluble form of kynurenine/a-aminoadipate aminotransferase from rat kidneyJ. Biol. Chem. 270,29330–29335 (1995).
M.P. Heyes, Quantification of 3-hydroxykynurenine in brain by high-performance liquid chromatography and electrochemical detectionJ. Chromatogr. 428,340–344 (1988).
A.G. Brox, F. Zhang, H. Guyda, RF. Gagnon, Subtherapeutic erythropoietin and insulin-like growth factor-I correct the anemia of chronic renal failure in the mouseKidney Int. 50,937–943 (1996).
W.C. Faquin, T.J. Schneider, M.A. Goldberg, Effect of inflammatory cytokines on hypoxia-induced erythropoietin productionBlood 79,1987–1994 (1992).
A.M. Goldberg, A.G. Glass, M.i. Cunningham, F.H. Bunn, The regulated expression of erythropoietin by two human hepatoma cell lines/’roc. Nail. Acad. Sci. USA 84,7972–7976 (1987).
J. Fandrey, S. Frede, W. Ehleben, T. Porwol, H. Acker, W. Jelkamann, Cobalt chloride and desfen-ioxamine antagonize the inhibition of erythropoietin production by reactive oxygen speciesKidney Int. 51,492–496 (1997).
J. Fandrey, S. Frede, W. Jelkmann, Role of hydrogen peroxide in hypoxia-induced erythropoietin productionBiochem. J. 303,507–510 (1994).
G.L. Wang, G.L. Semenza, Purification and characterization of hypoxia-inducible factor IJ. Biol. Chem. 270,1230–1237 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pawlak, D., Koda, M., Wołczyński, S., Mysliwiec, M., Buczko, W. (2003). Mechanism of Inhibitory Effect of 3- Hydroxykynurenine on Erythropoiesis in Patients with Renal Insufficiency. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_43
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0135-0_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4939-6
Online ISBN: 978-1-4615-0135-0
eBook Packages: Springer Book Archive